Heat Biologics (HTBX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HTBX Hot Sheet
Join SI Premium – FREE
Heat Biologics (NASDAQ: HTBX) reported Q2 EPS of ($0.62), $0.01 worse than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
